![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|6|4|393-416
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.6, Iss.4, 2000-03, pp. : 393-416
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
MDM2 Inhibitors for Pancreatic Cancer Therapy
Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 6, 2010-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The MYC Oncogene as a Cancer Drug Target
Current Cancer Drug Targets, Vol. 3, Iss. 3, 2003-06 ,pp. :